Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 45 citing articles:

Revitalizing Ancient Mitochondria with Nano‐Strategies: Mitochondria‐Remedying Nanodrugs Concentrate on Disease Control
Xingyu Long, Min Liu, Yayun Nan, et al.
Advanced Materials (2024) Vol. 36, Iss. 18
Closed Access | Times Cited: 26
Precise subcellular targeting approaches for organelle-related disorders
Gayong Shim, Yu Seok Youn
Advanced Drug Delivery Reviews (2024) Vol. 212, pp. 115411-115411
Closed Access | Times Cited: 9
Ameliorating Mitochondrial Dysfunction for the Therapy of Parkinson's Disease
Qing Yin Zheng, Hanghang Liu, Yifan Gao, et al.
Small (2024) Vol. 20, Iss. 29
Closed Access | Times Cited: 8
Collision of herbal medicine and nanotechnology: a bibliometric analysis of herbal nanoparticles from 2004 to 2023
Sinan Ai, Yake Li, Hui Juan Zheng, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Pathogenesis of Parkinson’s Disease
Bin Xiao, Zhidong Zhou, Yinxia Chao, et al.
Neurologic Clinics (2025)
Closed Access | Times Cited: 1
Mitochondria in brain diseases: Bridging structural-mechanistic insights into precision-targeted therapies
Jun Liao, Wenxiu He, Lisha Li, et al.
(2025), pp. 100016-100016
Open Access | Times Cited: 1
Versatile Copper-Chalcogenide-Based Nanoparticles for the Treatment of Brain Diseases
Shuyang Xie, Hualong Liu, Ke Yang, et al.
Nano Biomedicine and Engineering (2025)
Open Access | Times Cited: 1
Mitochondria-Targeted Delivery Strategy of Dual-Loaded Liposomes for Alzheimer’s Disease Therapy
Л. А. Васильева, Gulnara A. Gaynanova, Ф. Г. Валеева, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10494-10494
Open Access | Times Cited: 21
Recent advances of nanomaterials for intervention in Parkinson’s disease in the context of anti-inflammation
Ruoyu Zhang, Xiaotong Chen, Yuanyuan Cheng, et al.
Coordination Chemistry Reviews (2023) Vol. 502, pp. 215616-215616
Closed Access | Times Cited: 18
Role of F-actin-mediated endocytosis and exercise in mitochondrial transplantation in an experimental Parkinson's disease mouse model
Rachit Jain, Nusrat Begum, Shruti Rajan, et al.
Mitochondrion (2023) Vol. 74, pp. 101824-101824
Open Access | Times Cited: 16
Cell Membrane Camouflaged Biomimetic Nanoparticles as a Versatile Platform for Brain Diseases Treatment
Shiyu Wang, Longfei Yang, Wenya He, et al.
Small Methods (2024)
Closed Access | Times Cited: 7
Significance of Mitochondrial Dysfunction in the Pathogenesis of Parkinson's Disease
Alexander V. Blagov, Anton Y. Postnov, Vasily N. Sukhorukov, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 1, pp. 36-36
Open Access | Times Cited: 6
An Overview on the Physiopathology of the Blood–Brain Barrier and the Lipid-Based Nanocarriers for Central Nervous System Delivery
Francesca Susa, Silvia Arpicco, Candido Fabrizio Pirri, et al.
Pharmaceutics (2024) Vol. 16, Iss. 7, pp. 849-849
Open Access | Times Cited: 6
Linalool, a Fragrance Compound in Plants, Protects Dopaminergic Neurons and Improves Motor Function and Skeletal Muscle Strength in Experimental Models of Parkinson’s Disease
Wan‐Hsuan Chang, Hung‐Te Hsu, Chih‐Cheng Lin, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2514-2514
Open Access | Times Cited: 5
Uremic Toxin Receptor AhR Facilitates Renal Senescence and Fibrosis via Suppressing Mitochondrial Biogenesis
Hongyan Xie, Ninghao Yang, Li Lu, et al.
Advanced Science (2024) Vol. 11, Iss. 33
Open Access | Times Cited: 4
Intervening with nanozymes in aging-related diseases: Strategies for restoring mitochondrial function
Fanyong Yan, Dongyang Liu, Baoshan Zhao, et al.
Biomaterials Advances (2025) Vol. 169, pp. 214193-214193
Closed Access
MC16 promotes mitochondrial biogenesis and ameliorates acute and diabetic nephropathy
Austin Thompson, Kevin Hurtado, Jaroslav Janda, et al.
British Journal of Pharmacology (2025)
Closed Access
Modulation of Macrophage Polarization in Rheumatoid Arthritis Therapy via Targeted Delivery of Bulleyaconitine A
Shutong Li, Shao‐Yu Yang, Tianhua Li, et al.
ACS Applied Nano Materials (2025)
Closed Access
Microplastics/nanoplastics contribute to aging and age-related diseases: mitochondrial dysfunction as a crucial role
Liang Kong, Shuhao Li, Yu Fu, et al.
Food and Chemical Toxicology (2025) Vol. 199, pp. 115355-115355
Closed Access
Mitochondria targeted nanoparticles for the treatment of mitochondrial dysfunction-associated brain disorders
Amy Claire Buck, Gerald J. Maarman, Admire Dube, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 13
Open Access
The relationship between serum GDF15 levels and non-motor symptoms in Parkinson’s disease
Jianli Wang, Ting Geng, Xiaomei Yao, et al.
Neurological Research (2025), pp. 1-10
Closed Access
Astragalin-functionalized ultrasmall nanoparticles modulate the complement pathway to inhibit microglial synaptic phagocytosis for reducing anesthetic neurotoxicity
Gang Wang, Yaobao Han, Ke Peng, et al.
Materials Today Bio (2025) Vol. 32, pp. 101714-101714
Closed Access
Probiotic Membrane-Modified Nanocomposite Alleviates Inflammation and Microbiota Dysbiosis in Colitis by Scavenging Oxidative Stress and Restoring Immune Homeostasis
Huan Yang, Xu Zhang, Jianshuang Wu, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access
Microglial membrane-coated nanoparticles for ACSL4-siRNA delivery in Parkinson’s disease
Heyue Lu, Bo Zhang, Min Ge, et al.
Chemical Engineering Journal (2025) Vol. 509, pp. 161251-161251
Closed Access
Page 1 - Next Page

Scroll to top